ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2018

Selective Focus on Rare Hematologic Malignancies Misleads Risk-Benefit Assessment of Radioiodine Therapy of Thyroid Cancer.

Mohan DossPubMed ↗Publisher ↗

No numbers read from the abstract.